» Articles » PMID: 20937998

Natural History of Retinopathy of Prematurity in Infants Born Before 27 Weeks' Gestation in Sweden

Overview
Journal Arch Ophthalmol
Specialty Ophthalmology
Date 2010 Oct 13
PMID 20937998
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the natural history of retinopathy of prematurity (ROP) in 506 extremely preterm infants born before 27 weeks' gestation in Sweden during a 3-year period.

Methods: A national population-based study was performed in Sweden from April 1, 2004, to March 31, 2007. According to the study protocol, initial eye examinations were to be performed at postnatal week 5, and examinations were repeated until the retina was completely vascularized or until criteria for treatment were met. The examinations were to be performed weekly, enabling study of the course and severity of ROP. In infants without ROP or with mild ROP without progression during the latest examinations, further examinations were performed weekly or every other week from postmenstrual age 35 weeks.

Results: During the study, 368 infants (72.7%) developed ROP. Postmenstrual age at onset of ROP was significantly related to severity of ROP, even when controlling for gestational age (ie, the earlier the onset of ROP, the higher the risk of developing severe ROP). Site of onset of ROP was significantly related to gestational age at birth. The risk of nasal onset was almost doubled for every week of decrease in gestational age at birth. Nasal onset was associated with severe ROP, even after adjusting for gestational age at birth.

Conclusion: This population-based study confirms results of the Cryotherapy for Retinopathy of Prematurity study and shows new correlations regarding time and site of onset of ROP, both of which are associated with disease severity.

Citing Articles

Retinopathy of Prematurity in Extreme Preterm and Extreme Low-birth-weight Infants: Incidence, Course, and Risk Factors.

Lekha T, Balakrishnan D, Giridhar A, Alex D, Goyal A Middle East Afr J Ophthalmol. 2024; 30(3):136-140.

PMID: 39444990 PMC: 11495289. DOI: 10.4103/meajo.meajo_15_24.


[Interpretation of the UK screening and treatment of retinopathy of prematurity updated 2022 guidelines].

Dong X, Li J, Luo K, Tang J, Mu D Zhongguo Dang Dai Er Ke Za Zhi. 2024; 26(5):437-443.

PMID: 38802901 PMC: 11135053. DOI: 10.7499/j.issn.1008-8830.2311073.


Development and validation of an artificial intelligence based screening tool for detection of retinopathy of prematurity in a South Indian population.

Parthasarathy Rao D, Savoy F, Tan J, Fung B, Bopitiya C, Sivaraman A Front Pediatr. 2023; 11:1197237.

PMID: 37794964 PMC: 10545957. DOI: 10.3389/fped.2023.1197237.


Screening and Risk Factors for Retinopathy of Prematurity in a Tertiary Care Hospital in Cairo, Egypt.

Noor M, Elbarbary M, Embabi S, Zaki M, Awad H, Al-Feky M Clin Ophthalmol. 2022; 16:3257-3267.

PMID: 36211718 PMC: 9533779. DOI: 10.2147/OPTH.S383493.


PRO-OXIDANTS AND ANTIOXIDANTS IN RETINOPATHY OF PREMATURITY.

Banjac L, Banjac G, Kotur-Stevuljevic J, Spasojevic-Kalimanovska V, Gojkovic T, Bogavac-Stanojevic N Acta Clin Croat. 2019; 57(3):458-463.

PMID: 31168178 PMC: 6536293. DOI: 10.20471/acc.2018.57.03.08.